Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × mirdametinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 3 Neurofibromatoses 3 Neurofibroma, Plexiform 2 Neurofibroma 2 Melanoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vascular Malformations 1 Solid Tumor, Adult 1 Skin Diseases, Vascular 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Oligodendroglioma 1 Neurocytoma 1 Neoplasms, Neuroepithelial 1 NF1 1 Multiple Myeloma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 KRAS Mutant Non-Small Cell Lung Cancer 1 Glioma 1 Glioblastoma 1 Ganglioneuroma 1 Ganglioglioma 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Temozolomide 405 Radiotherapy 202 Bevacizumab 156 Radiation 80 Magnetic Resonance Spectroscopy 76 Lomustine 49 Surgical Procedures, Operative 45 Carmustine 41 pembrolizumab 40 Irinotecan 38 Nivolumab 32 Specimen Handling 27 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Drug Therapy 22 Aminolevulinic Acid 20 Cyclophosphamide 19 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Blood Specimen Collection 14 Vorinostat 13 Sorafenib 13 Ipilimumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡